"Following a thorough analysis of our previous Phase 2b data and trial design, we believe that with the preferred modified release formulation and future trial design optimization, we can advance a competitive oral GLP-1 molecule into registration enabling studies, with the goal of addressing the present and persistent medical needs of people living with obesity." The ongoing open-label, randomized study is evaluating the pharmacokinetics and safety of immediate- and modified release formulations of danuglipron administered orally in healthy adults 18 years or older
Lyophilized (Freeze-Dried) Powder When you receive your vial from us, it contains a small, solid puck of lyophilized GHK-Cu
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and salt
an overly acidic environment may lead to the dissociation of the copper ion from the peptide, compromising the efficacy and color of the product